ARCA biopharma, Inc.
(NASDAQ CM: ABIO)
Rigrodsky Law, P.A. is investigating ARCA biopharma, Inc. (“ARCA”) regarding possible breaches of fiduciary duties and other violations of law related to ARCA’s agreement to merge with Oruka Therapeutics.
(NASDAQ CM: ABIO)
Rigrodsky Law, P.A. is investigating ARCA biopharma, Inc. (“ARCA”) regarding possible breaches of fiduciary duties and other violations of law related to ARCA’s agreement to merge with Oruka Therapeutics.